As of 2025-06-03, the EV/EBITDA ratio of Guangdong Hybribio Biotech Co Ltd (300639.SZ) is -3.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300639.SZ's latest enterprise value is 2,995.05 mil CNY. 300639.SZ's TTM EBITDA according to its financial statements is -855.04 mil CNY. Dividing these 2 quantities gives us the above 300639.SZ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 28.2x | 26.8x |
| Forward P/E multiples | 8.7x - 14.4x | 9.8x |
| Fair Price | (30.91) - (18.02) | (23.24) |
| Upside | -651.9% - -421.9% | -514.9% |
| Date | EV/EBITDA |
| 2025-05-28 | -3.43 |
| 2025-05-27 | -3.53 |
| 2025-05-26 | -3.52 |
| 2025-05-23 | -3.66 |
| 2025-05-22 | -3.31 |
| 2025-05-21 | -3.36 |
| 2025-05-20 | -3.40 |
| 2025-05-19 | -3.35 |
| 2025-05-16 | -3.38 |
| 2025-05-15 | -3.33 |
| 2025-05-14 | -3.33 |
| 2025-05-13 | -3.34 |
| 2025-05-12 | -3.29 |
| 2025-05-09 | -3.25 |
| 2025-05-08 | -3.28 |
| 2025-05-07 | -3.20 |
| 2025-05-06 | -3.21 |
| 2025-04-30 | -3.12 |
| 2025-04-29 | -3.09 |
| 2025-04-28 | -3.02 |
| 2025-04-25 | -3.09 |
| 2025-04-24 | -3.12 |
| 2025-04-23 | -3.16 |
| 2025-04-22 | -3.16 |
| 2025-04-21 | -3.12 |
| 2025-04-18 | -3.09 |
| 2025-04-17 | -3.10 |
| 2025-04-16 | -3.07 |
| 2025-04-15 | -3.16 |
| 2025-04-14 | -3.16 |
| 2025-04-11 | -3.12 |
| 2025-04-10 | -3.15 |
| 2025-04-09 | -3.07 |
| 2025-04-08 | -3.03 |
| 2025-04-07 | -2.90 |
| 2025-04-03 | -3.63 |
| 2025-04-02 | -3.62 |
| 2025-04-01 | -3.65 |
| 2025-03-31 | -3.50 |
| 2025-03-28 | -3.60 |
| 2025-03-27 | -3.66 |
| 2025-03-26 | -3.63 |
| 2025-03-25 | -3.59 |
| 2025-03-24 | -3.65 |
| 2025-03-21 | -3.80 |
| 2025-03-20 | -3.87 |
| 2025-03-19 | -3.86 |
| 2025-03-18 | -3.89 |
| 2025-03-17 | -3.92 |
| 2025-03-14 | -3.95 |